A case of thoracic SMARCA4-Deficient undifferentiated tumor successfully treated with combination Ipilimumab-Nivolumab

被引：7

作者：

Nakano, Yoshio ^{[1
,3
]}

Sekinada, Daisuke ^{[1
]}

Kuze, Yusuke ^{[1
]}

Okamoto, Norio ^{[1
]}

Gohma, Iwao ^{[1
]}

Yasuhara, Yumiko ^{[2
]}

机构：

[1] Sakai City Med Ctr, Dept Resp Med, Sakai, Japan

[2] Sakai City Med Ctr, Dept Pathol, Sakai, Japan

[3] Sakai City Med Ctr, Dept Resp Med, 1-1-1,Ebaraji Cho,West Ward, Sakai, Osaka 5938304, Japan

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期

关键词：

case report; SMARCA4; undifferentiated tumors;

D O I：

10.1002/ccr3.6745

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thoracic SMARCA4-deficient undifferentiated tumors are rare, with poor prognosis. A 73-year-old man presented to our hospital with dyspnea. Computed tomography-guided biopsy revealed a SMARCA4-deficient undifferentiated tumor. The patient was treated with combination ipilimumab-nivolumab. The tumor reduced in size after two courses.

引用

页数：5

共 16 条

[1] Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study [J].

Anzic, Nina ;

Krasniqi, Fatime ;

Eberhardt, Anna-Lena ;

Tzankov, Alexandar ;

Haslbauer, Jasmin Dionne .

CASE REPORTS IN ONCOLOGY, 2021, 14 (02) :706-715

[2]

Divisi Duilio, 2021, Cancer Med J, V4, P115

[3] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[4] Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer [J].

Hellmann, M. D. ;

Paz-Ares, L. ;

Bernabe Caro, R. ;

Zurawski, B. ;

Kim, S. -W. ;

Carcereny Costa, E. ;

Park, K. ;

Alexandru, A. ;

Lupinacci, L. ;

de la Mora Jimenez, E. ;

Sakai, H. ;

Albert, I. ;

Vergnenegre, A. ;

Peters, S. ;

Syrigos, K. ;

Barlesi, F. ;

Reck, M. ;

Borghaei, H. ;

Brahmer, J. R. ;

O'Byrne, K. J. ;

Geese, W. J. ;

Bhagavatheeswaran, P. ;

Rabindran, S. K. ;

Kasinathan, R. S. ;

Nathan, F. E. ;

Ramalingam, S. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :2020-2031

[5] Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor [J].

Henon, C. ;

Blay, J. -Y. ;

Massard, C. ;

Mir, O. ;

Bahleda, R. ;

Dumont, S. ;

Postel-Vinay, S. ;

Adam, J. ;

Soria, J. -C. ;

Le Cesne, A. .

ANNALS OF ONCOLOGY, 2019, 30 (08) :1401-1403

[6] Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC [J].

Herbst, Roy S. ;

Giaccone, Giuseppe ;

de Marinis, Filippo ;

Reinmuth, Niels ;

Vergnenegre, Alain ;

Barrios, Carlos H. ;

Morise, Masahiro ;

Felip, Enriqueta ;

Andric, Zoran ;

Geater, Sarayut ;

Ozguroglu, Mustafa ;

Zou, Wei ;

Sandler, Alan ;

Enquist, Ida ;

Komatsubara, Kimberly ;

Deng, Yu ;

Kuriki, Hiroshi ;

Wen, Xiaohui ;

McCleland, Mark ;

Mocci, Simonetta ;

Jassem, Jacek ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14) :1328-1339

[7] Cardiovascular toxicities associated with immune checkpoint inhibitors [J].

Hu, Jiun-Ruey ;

Florido, Roberta ;

Lipson, Evan J. ;

Naidoo, Jarushka ;

Ardehali, Reza ;

Tocchetti, Carlo G. ;

Lyon, Alexander R. ;

Padera, Robert F. ;

Johnson, Douglas B. ;

Moslehi, Javid .

CARDIOVASCULAR RESEARCH, 2019, 115 (05) :854-868

[8] Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report [J].

Iijima, Yuki ;

Sakakibara, Rie ;

Ishizuka, Masahiro ;

Honda, Takayuki ;

Shirai, Tsuyoshi ;

Okamoto, Tsukasa ;

Tateishi, Tomoya ;

Sakashita, Hiroyuki ;

Tamaoka, Meiyo ;

Takemoto, Akira ;

Kumaki, Yuichi ;

Ikeda, Sadakatsu ;

Miyazaki, Yasunari .

IMMUNOTHERAPY, 2020, 12 (08) :563-569

[9] Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma [J].

Kawachi, Hayato ;

Kunimasa, Kei ;

Kukita, Yoji ;

Nakamura, Harumi ;

Honma, Keiichiro ;

Kawamura, Takahisa ;

Inoue, Takako ;

Tamiya, Motohiro ;

Kuhara, Hanako ;

Nishino, Kazumi ;

Mizote, Yu ;

Akazawa, Takashi ;

Tahara, Hideaki ;

Kumagai, Toru .

IMMUNOTHERAPY, 2021, 13 (10) :799-806

[10] SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas [J].

Le Loarer, Francois ;

Watson, Sarah ;

Pierron, Gaelle ;

de Montpreville, Vincent Thomas ;

Ballet, Stelly ;

Firmin, Nelly ;

Auguste, Aurelie ;

Pissaloux, Daniel ;

Boyault, Sandrine ;

Paindavoine, Sandrine ;

Dechelotte, Pierre Joseph ;

Besse, Benjamin ;

Vignaud, Jean Michel ;

Brevet, Marie ;

Fadel, Elie ;

Richer, Wilfrid ;

Treilleux, Isabelle ;

Masliah-Planchon, Julien ;

Devouassoux-Shisheboran, Mojgan ;

Zalcman, Gerard ;

Allory, Yves ;

Bourdeaut, Franck ;

Thivolet-Bejui, Francoise ;

Ranchere-Vince, Dominique ;

Girard, Nicolas ;

Lantuejoul, Sylvie ;

Galateau-Salle, Francoise ;

Coindre, Jean Michel ;

Leary, Alexandra ;

Delattre, Olivier ;

Blay, Jean Yves ;

Tirode, Franck .

NATURE GENETICS, 2015, 47 (10) :1200-+

← 1 2 →